Semax vs Selank: The Nootropic Peptides Your Psychiatrist Doesn't Know About

Two peptides. Both developed behind the Iron Curtain. Both sitting in a category your psychiatrist almost certainly has not heard of. And both, according to a growing body of research - most of it in Russian - capable of doing things that conventional cognitive enhancers struggle to replicate cleanly: sharpening focus without the crash, easing anxiety without blunting you, and potentially rebuilding the brain chemistry that chronic stress has quietly eroded.

Semax and Selank are not supplements. They are synthetic neuropeptides - engineered molecules that act directly on the brain's signaling systems. If you have spent any time in nootropic or peptide communities, you have probably encountered both names. But most of the coverage treats them as interchangeable "Russian brain peptides," which gets the category right and nearly everything else wrong.

They work through different mechanisms, serve different primary purposes, and suit different people. What follows is an honest look at both.

The Soviet Lab That Invented Both

To understand Semax and Selank, you need to understand their origin: the Institute of Molecular Genetics of the Russian Academy of Sciences, where both compounds were developed in the 1980s and 1990s as part of a state-funded program to enhance cognitive performance and resilience in high-demand personnel.

The Soviet Union - and later Russia - had a parallel pharmaceutical industry largely inaccessible to Western researchers. Where the West invested in SSRIs and benzodiazepines, Soviet scientists investigated neuropeptide fragments: small chains of amino acids derived from naturally occurring brain proteins, modified to survive degradation and cross the blood-brain barrier in meaningful concentrations.

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue of the adrenocorticotropic hormone (ACTH) 4-10 fragment. It was developed primarily as a neuroprotective agent and approved in Russia and Ukraine in the 1990s for stroke recovery, traumatic brain injury, and optic nerve disease. In practice, it became one of the most widely used cognitive enhancers in Russian clinical settings - and eventually in Western nootropic circles.

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. It was developed as an anxiolytic - a compound to reduce anxiety - without the sedation and dependence risks of benzodiazepines. Like Semax, it received regulatory approval in Russia and is available at Russian state pharmacies as a 0.15% nasal spray.

Both peptides are available in many countries as research chemicals. Neither is FDA-approved or sold as a pharmaceutical in the United States or EU.

How Semax Works: Focus, Drive, and BDNF

Semax acts primarily through two mechanisms: modulation of the melanocortin system (via its ACTH ancestry) and robust upregulation of neurotrophic factors - particularly brain-derived neurotrophic factor (BDNF).

The melanocortin pathway matters because ACTH fragments influence dopaminergic and serotonergic signaling in prefrontal and limbic regions - the areas governing attention, motivation, and executive function. Users describe the effect as a sharpening of focus without the stimulant edge of amphetamines or the jitteriness of high-dose caffeine. It is more "clear" than "driven" - more signal, less noise.

The BDNF effect is where Semax gets genuinely interesting from a neuroscience standpoint. BDNF is often called the brain's "fertilizer" - it supports the survival of existing neurons, promotes the growth of new neurons and synapses (neuroplasticity), and is strongly linked to learning, memory consolidation, and mood regulation. Semax has been shown in animal models and some human studies to significantly increase BDNF expression in the hippocampus and cortex.

Additional mechanisms include:

• VEGF upregulation: Vascular endothelial growth factor supports cerebral blood flow and angiogenesis.
• NGF stimulation: Nerve growth factor supports cholinergic neurons critical for memory and learning.
• Dopaminergic enhancement: Semax modulates dopamine turnover in the striatum and prefrontal cortex.

Semax is administered intranasally - rapid onset (15-30 minutes), duration roughly 4-8 hours. Neurotrophin effects are cumulative and persist beyond the acute cognitive window. See our full Semax guide for detailed dosing protocols.

How Selank Works: The Anxiety Equation

Selank's primary mechanism is modulation of the GABAergic system - the same system targeted by benzodiazepines and alcohol, but via a fundamentally different pathway.

Benzodiazepines bind directly to GABA-A receptors as positive allosteric modulators, producing powerful sedation and rapid tolerance. Selank does not bind to GABA-A receptors directly. Instead, it appears to influence GABA metabolism and turnover through less direct pathways, producing anxiolytic effects without the full sedation profile, and - critically - without inducing the receptor downregulation that leads to dependence.

Other confirmed mechanisms include:

• Serotonin regulation: Modulates serotonergic signaling, contributing to mood-stabilizing and pro-social effects.
• BDNF upregulation: Like Semax, Selank has been shown to increase BDNF expression.
• IL-6 modulation: Selank appears to influence interleukin-6, an inflammatory cytokine elevated during chronic stress.

The net effect for most users is a reduction in baseline anxiety without sedation or cognitive blunting. Unlike benzodiazepines, which produce a calm-but-foggy state, Selank tends to be described as "clear calm."

The BDNF Connection: Why Both Peptides Matter for Brain Health

Brain-derived neurotrophic factor (BDNF) deserves its own section because it is central to understanding why these peptides represent something qualitatively different from stimulants or anxiolytics.

BDNF is a protein expressed throughout the central nervous system, most densely in the hippocampus and cortex. Its functions include supporting neuron survival during stress, promoting synaptic plasticity, facilitating long-term memory formation, and modulating mood - with low BDNF consistently linked to depression in both animal models and human studies.

Chronic stress suppresses BDNF. So does poor sleep, sedentary behavior, and certain commonly prescribed medications. Exercise and antidepressants both work partly by restoring BDNF levels.

What makes Semax particularly interesting is that its BDNF-upregulating effect appears to be acute and robust. A 2009 study in Journal of Neurochemistry found that Semax increased BDNF mRNA expression in the rat hippocampus by up to 1.4-fold within hours of administration.

This is the mechanistic basis for why Semax and Selank are often described as potentially neuroprotective, not merely symptom-managing. The evidence is preliminary and mostly animal-model, but the direction is consistent.

Semax vs Selank: The Comparison

Who Is Semax Best For?

Semax tends to suit people whose primary complaint is a deficit in cognitive output: difficulty initiating tasks, brain fog that feels like running through mud, reduced working memory, or recovering cognitive function after illness, injury, or prolonged stress.

Primary use cases:

• Post-COVID cognitive recovery: Long-COVID "brain fog" has driven significant anecdotal interest in Semax, given its neuroprotective and BDNF-upregulating profile.
• Work-related cognitive demands: Programmers, writers, and professionals who need sustained focused work without stimulant side effects.
• Stroke and TBI recovery: The area with the most clinical evidence from Russian studies.
• Attention difficulties: Some users with ADHD-type patterns report subjective improvement in task initiation and focus.

Semax is less suited to people whose primary issue is anxiety. Its mild stimulant quality can amplify anxiety in people who are already running hot - this is the most common negative experience reported, and it is almost always dose-dependent.

Who Is Selank Best For?

Selank fits a different profile: people whose cognitive difficulties are downstream of anxiety - where the brain fog, distraction, and difficulty thinking clearly are symptoms of a chronically activated stress response rather than a primary attentional deficit.

Primary use cases:

• Generalized anxiety: Multiple Russian studies show significant reduction in anxiety scores comparable to low-dose benzodiazepines - without the dependence risk.
• Stress resilience: Regular use appears to reduce reactivity to stressors over time rather than simply blunting the acute response.
• Anxiety-driven cognitive impairment: If your brain fog comes with racing thoughts, rumination, or a persistent sense of dread, Selank is the more targeted intervention. See our full brain fog article for more on this distinction.
• Sleep anxiety: Some users report improved sleep onset when using Selank in the evening - not through sedation, but by reducing anxious rumination.

Selank is less suited to people whose primary need is direct cognitive enhancement - it will not make you sharper in the way Semax does for cognitively deficient states.

The Morning Semax / Evening Selank Protocol

The most effective application of these two peptides combines them: specifically for people whose brain fog has both components - cognitive underperformance and anxiety-driven mental noise.

The logic of the combination is coherent and well-supported by the mechanistic profiles:

• Morning Semax: Capitalizes on the stimulating quality when it is useful - cognitive activation, task initiation, focus for demanding work
• Evening Selank: Addresses the anxiety or cognitive fatigue that often emerges in the afternoon, preparing for calmer sleep-onset
• Both upregulate BDNF through different pathways - potentially producing additive neurotrophin effects that compound over a course of weeks

This pairing is sometimes called the "Morning Clarity / Evening Calm" protocol in nootropic communities, and it maps neatly onto the day's natural cognitive and emotional demands. For a broader view of how to build a peptide-based cognitive stack, see our Cognitive Stack article.

Practical dosing framework:

• Morning: Semax (0.1% solution, 2-3 drops per nostril)
• Evening: Selank (0.15% solution, 2-3 drops per nostril)
• Cycle: 10 days on, 10 days off - or 5 days on, 2 days off
• Start low: 1 drop per nostril for each before scaling. Sensitivity varies considerably between individuals.

What this protocol does not fix: structural contributors to brain fog - poor sleep, sedentary lifestyle, nutrient deficiencies, thyroid dysfunction, anemia. These peptides work better as enhancements to an optimized baseline than as replacements for foundational health practices.

Stacking Protocols: Peptides and Other Compounds

Beyond the Semax + Selank combination, both peptides are used in broader stacking protocols with other compounds. Key considerations:

• Semax + stimulant caffeine/modafinil: Use caution. Semax is mildly stimulating; stacking with other stimulants can push toward restlessness and disrupted sleep. Reduce Semax dose if combining.
• Selank + SSRIs: Selank's serotonin modulation is mechanistically different from SSRIs. Do not discontinue prescribed antidepressants without medical supervision.
• Semax + BPC-157: Complementary mechanisms - one central, one peripheral. No interaction concerns.

For a comprehensive guide to what you can and cannot safely combine, see our Peptide Stacking 101 article.

Evidence Tiers: What the Research Actually Says

One of the things WellSourced tries to do honestly is be clear about the difference between "there is a plausible mechanism" and "there is robust clinical evidence." Here is where Semax and Selank land:

Semax - Evidence Summary:

• Strong (Tier 1): Neuroprotection and cognitive recovery in acute stroke and TBI - multiple Russian RCTs, clinically approved use.
• Moderate (Tier 2): BDNF upregulation - well-replicated in animal models, corroborated in some human biomarker studies.
• Preliminary (Tier 3): Cognitive enhancement in healthy subjects - primarily case series, observational data, and anecdotal reports. No well-designed Western RCT.
• Speculative (Tier 4): Long-COVID recovery, ADHD - mechanistic rationale exists; no controlled evidence.

Selank - Evidence Summary:

• Strong (Tier 1): Anxiolytic effect - multiple Russian double-blind studies showing significant reduction in generalized anxiety.
• Moderate (Tier 2): Stress response modulation - consistent animal and some human evidence for reduced cortisol reactivity.
• Preliminary (Tier 3): Cognitive enhancement - some improvement in learning and memory in animal models; human evidence limited.
• Speculative (Tier 4): Benzo tapering support, sleep optimization - mechanistically possible; clinical evidence very limited.

How They Compare to Conventional Options

Semax and Selank vs SSRIs

SSRIs (selective serotonin reuptake inhibitors) work by blocking serotonin reuptake in synaptic clefts. They require weeks to reach therapeutic effect and carry a meaningful side effect profile. Selank's serotonin modulation is mechanistically different - it affects synthesis and metabolism rather than reuptake. Selank is not a replacement for SSRIs in clinical depression or severe anxiety. Semax has no direct serotonergic mechanism.

Semax and Selank vs Benzodiazepines

Benzodiazepines are among the most effective acute anxiolytics - and among the most problematic for long-term use due to tolerance, dependence, and severe withdrawal. Selank's GABAergic activity is indirect and produces a substantially gentler effect. For chronic anxiety not severe enough to require a benzodiazepine, Selank represents a genuinely interesting alternative with a much more favorable dependence profile.

Semax vs Modafinil

Modafinil is the benchmark cognitive enhancer - well-studied, effective for wakefulness, and has far more robust Western clinical evidence. Semax has a cleaner side effect profile at standard doses and offers neuroprotective and neurotrophin effects that modafinil does not. For a gentler, potentially neuroprotective approach with a different mechanism and fewer acute side effects, Semax is an interesting alternative - particularly for people who find modafinil too activating or disruptive to sleep.

A Word on Sourcing

Semax and Selank are available from research chemical suppliers. Quality varies enormously. Key considerations:

• Third-party testing: Reputable suppliers provide certificates of analysis (CoA) from independent labs confirming identity, purity, and absence of contaminants.
• Storage: Both peptides are sensitive to heat and moisture. Lyophilized powder is more stable than pre-mixed solution.
• Legal status: In the US, both are sold as "research chemicals" - legal to purchase but not approved for human consumption.

Frequently Asked Questions

The Bottom Line

Semax and Selank are not interchangeable, and they are not magic. They are two of the more mechanistically interesting neuropeptides available outside a clinical setting - each with a coherent scientific rationale, a reasonable evidence base, and a long safety record in the populations where they have been clinically used.

If your dominant complaint is cognitive underperformance - fog, slow processing, difficulty focusing without anxiety as the primary driver - Semax is the more targeted intervention, and its BDNF and neuroprotective profile makes it interesting beyond the acute window.

If your dominant complaint is anxiety-driven cognitive impairment - where stress, rumination, and threat-detection overactivity are the primary obstacles to clear thinking - Selank addresses the root cause more directly and without the dependence concerns of pharmaceutical anxiolytics.

For many people, the most effective approach is both, used thoughtfully with appropriate cycling and attention to dose - the Morning Semax / Evening Selank protocol is well-supported by the mechanisms and widely reported in practice.

What neither will do is compensate for the fundamentals: sleep, movement, nutrition, and stress management. Address those first. Layer these compounds on a solid baseline, and the evidence suggests they may meaningfully extend what is possible.

For deeper profiles on each compound, see our Semax peptide profile. For how peptides compare to other cognitive enhancement approaches, see our Cognitive Stack article and Brain Fog article.